Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syros Pharmaceuticals, Inc. - Common Stock (NQ:SYRS)

0.1172 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Syros Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
From Syros Pharmaceuticals
Via Business Wire
Syros to Present at Upcoming Investor Conferences in September
From Syros Pharmaceuticals
Via Business Wire
Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
From Syros Pharmaceuticals
Via Business Wire
Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer
From Syros Pharmaceuticals
Via Business Wire
Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From Syros Pharmaceuticals
Via Business Wire
Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference
From Syros Pharmaceuticals
Via Business Wire
Syros to Host Key Opinion Leader Webcast Series on Targeted Hematology Portfolio
From Syros Pharmaceuticals
Via Business Wire
Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
From Syros Pharmaceuticals
Via Business Wire
Syros to Report First Quarter 2021 Financial Results on Thursday May 6, 2021
From Syros Pharmaceuticals
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.